Module 10 Part 2 Performing drug susceptibility testing on solid media 1 Learning objectives At the end of this module you will be able to: explain the different methods for performing DST; perform and interpret the proportion method; record and report DST results; store strains. 2 Content outline • Drug susceptibility test methods: – direct – Indirect • Proportion method: technical protocol and interpretation criteria • Recording and reporting DST results • Storage of strains 3 Direct drug susceptibility method: proportion method • Sputa with smear grading of 2+ or more can be used as pure cultures after decontamination using standard procedure. • The neutralized suspension is used for inoculation directly onto drug-containing and drug-free media, according to the proportion method (see below). • Inoculum size is adjusted according to the number of AFB observed during smear microscopy of concentrated sputum. • Identification should be performed before results are released. 4 Example of a susceptibility test, proportion method, inoculated directly after decontamination from the sample (4 AFB/field) Courtesy of Dr Isabel N. de Kantor, Buenos Aires, Argentina 5 Direct drug susceptibility method: advantages • Bacillary populations more representative of those existing in vivo. • Takes 3–4 weeks less than indirect testing. 6 Direct drug susceptibility method: disadvantages • Only for highly positive smear. • NOT possible in liquid culture. • High contamination rate. • Difficult to calibrate (live + dead bacilli). • Failure rate: 10–15% 7 Indirect drug susceptibility methods • Organisms isolated in culture. • A homogeneous suspension of growth is inoculated onto control and drugcontaining egg-based solid media. 8 Indirect drug susceptibility methods 9 Indirect drug susceptibility method: proportion method • The proportion method is the most widely used method for DST and is currently used as a reference for testing new methods. • The proportion method determines the percentage of growth (number of colonies) of a defined inoculum on a drug-free control medium vs. growth on culture media containing the critical concentration of an anti-TB drug. • The critical drug concentration, as well as the critical proportion of resistant colonies, has been evaluated from clinical data. 10 Indirect proportion method • A pure culture of tubercle bacilli (test strain) in the active phase of growth (2–4 weeks). In the absence of sufficient growth (<20 colonies, 1+), DST should not be performed unless the culture comes from a patient who has completed antiTB treatment. From cultures with scarce growth, the bacillary population used for performing DST may not be representative of those existing in vivo. 11 Proportion method: critical parameters Use of LJ medium and a critical proportion of 1% of growth for all 4 drugs Critical drug concentration Drug Critical conc. (μg/ml) Streptomycin 4 Isoniazid 0.2 Rifampicin 40 Ethambutol 2 Critical % 1 1 1 1 12 Procedure Sediment for 15 min and transfer the supernatant to another tube TOUCH ALL COLONIES! 5 ml Sterile distilled water BEADS Media should be from the same batch Vortex 13 Calibration of the bacterial suspension Calibrate the inoculum to 1 MacFarland by comparing with standard 1 MacFarland suspension on a dark background. SN 1 MacFarland suspension Clumps and beads 14 Inoculation • Loop (10 μl, diameter 3 mm) • Calibrated pipettes 15 Procedure – inoculum with loop GC GC S S I I R R E E 16 0.01 ml twice 2 ml distilled water BEADS MacFarland 1 10–2 + inoculum of 2 GC with suspension 10–4 Procedure – inoculum with loop ../.. GC GC S S I I R R E E 17 twice 2 ml distilled water 10–1 2 ml distilled water 10–3 + inoculum of 2 GC with suspension 10–5 Procedure – inoculum with pipette 0.5 ml 0.5 ml BEADS 4.5 ml distilled water 10–1 0.5 ml 0.5 ml 0.5 ml 0.5 ml 4.5 ml4.5 ml 4.5 ml 4.5 ml4.5 ml 4.5 ml distilled distilled distilleddistilled distilled distilled water water waterwater water water 10–2 10–3 10–4 0.5 ml 4.5 ml 4.5 ml 4.5 ml distilled distilled distilled water water water 10–5 4.54.5 mlml distilled distilled water water 10–6 18 Inoculum with pipette GC GC GC GC 0.1 ml 0.1 ml S S I I R R 10–3 10–5 E E 19 Inoculum with pipette ../ GC GC GC GC 0.1 ml 0.1 ml S S I I R R 10–4 10–6 E E 20 Incubation • Incubate at 35–37 ºC in slanted position, loose caps. • At 48 hours: • tighten caps • check for contaminants • move to upright position 21 Reading results • Read after 4 weeks as a provisional result and after 6 weeks for the definitive interpretation of result. • The growth on GC tube 1/100 should allow easy counting of 30–100 colonies. • If fewer than 20 colonies have grown on this control, report only if resistant (repeat if susceptible). • A strain is resistant if the medium containing the critical concentration of the corresponding drug shows more colonies than the GC with the 1% inoculum . • “Borderline cases” (about 1% growth on drug-containing medium) should be reported as resistant and retested. • If the criteria described above are met and quality control of the batch meets the standards, the result is interpreted and reported as “susceptible” or “resistant” using the report form sheet. 22 Interpretation Growth on control tubes (>20 colonies on GC) and no growth on drug tubes SENSITIVE TO ALL DRUGS 23 Interpretation Growth on control tubes (>20 colonies) and number of colonies on isoniazid tube ≥ number of colonies on control tube 1/100 RESISTANT TO ISONIAZID 24 Interpretation Growth on control tubes (>20 colonies) and number of colonies on isoniazid tube < number of colonies on control tube 1/100 SENSITIVE TO ISONIAZID 25 Interpretation Growth on control tubes (>20 colonies) and number of colonies on rifampicin tube ≥ number of colonies on control tube 1/100 RESISTANT TO RIFAMPICIN 26 Interpretation Growth on control tubes (>20 colonies) and number of colonies on rifampicin tube < number of colonies on control tube 1/100 SENSITIVE TO RIFAMPICIN 27 Interpretation Growth on control tubes (>20 colonies) and number of colonies on streptomycin tube ≥ number of colonies on control tube 1/100 RESISTANT TO STREPTOMYCIN 28 Interpretation Growth on control tubes (>20 colonies) and number of colonies on streptomycin tube < number of colonies on control tube 1/100 SENSITIVE TO STREPTOMYCIN 29 Interpretation Growth on control tubes (>20 colonies) and number of colonies on ethambutol tube ≥ number of colonies on control tube 1/100 RESISTANT TO ETHAMBUTOL 30 Interpretation Growth on control tubes (>20 colonies) and number of colonies on iethambutol tube < number of colonies on control tube 1/100 SENSITIVE TO ETHAMBUTOL 31 Interpretation Growth on control tubes (>20 colonies) and number of colonies on isoniazid tube and on rifampicin ≥ number of colonies on control tube 1/100 MULTIDRUG-RESISTANT (MDR) 32 Interpretation No growth on control tubes (or <20 colonies on GC) and no growth on drug tubes INVALID RESULT – REPEAT 33 Proportion method ‒ advantages and disadvantages Advantages: Disadvantages: • Standardization of • Influenced by degree the size inoculum is not critical • Simple of dispersion of the inoculum suspension 34 Possible errors • Related to drug concentrations and stability: – preparation of drug solutions and drug-containing media; – excessive or prolonged heat during inspissation – steaming of media; – improper storage of drug solutions and drug-containing media. Related to media quality: – excessive moisture on the surface of the medium; – excessive dehydration of the medium. Related to the inoculum: – use of an inoculum not representative of the bacterial population; – use of too little inoculum; – presence of large aggregates of bacteria. Related to NTM contamination: – failure to recognize the simultaneous presence of MTB complex and other mycobacteria. Use only pure M. tuberculosis cultures. 35 Quality assurance issues • Every new batch of drug-containing media prepared for DST must be quality-controlled. • For each drug, a slant of the critical concentration and media with lower drug concentrations are tested with H37Rv strain. • Compare results with the MIC of H37Rv. • External quality control should be organized and supervised annually by the national research laboratory, using a panel of 20 test strains provided by the SRL network. 36 Recording and reporting form Request and reporting form for TB culture and Drug Susceptibility Test (DST) Patient identification (ID): TB register number:____________ Previous TB register number:____________ MDR register number:_____________ Surname and first name of patient:________________________________ Address: _________________________________ 1 week Date reported Identification ID test 2** ID test 1** PNB History: new (never treated before for ?1 month) relapse failure Cat.1 return after default Cat.2 chronic excretor Drug in µg/ml* Cat.4concentrations (second-line drugs) MDR contact Other _________________ uncertain Final results ID test 3** Ethambutol-4 Ethambutol-2 Rifampicin-4 Previous treatment: Rifampicin-2 Isoniazid-4 Isoniazid-2 Control -4 Control -2 Reading time TB Disease type and treatment history Site: pulmonary extrapulmonary (specify):_______________ Streptomycin-4 Streptomycin-2 Quantified results of growth / reactions *HIV-status: Pos / Neg / Unknown _________________________________ Resistance profile Ward / Department: __________________ Age (yrs):_____ Sex:____ Origin of request: 4 weeks 6 weeks Region ID:_______________ Date: _____/______/20_____ Date specimen was collected: 1 week Local laboratory: 4 weeks 6 weeks District ID:_______________ Local laboratory ID:________________ Signature:________________ ____/____/20____ st nd Specimen ID number:_______________ rd smear result: 1 ____ 2 ____ 3 ____ specimen microscopy technique used: hot Ziehl-Neelsen cold staining fluorescence direct smear concentrated smear Request for testing at the reference laboratory: Legend: S = susceptible; R = resistant; C = contaminated; ND = not done ID # ____________ Reason: diagnosis Specimen: sputum follow-up at …. monthsEthambutol during treatment Streptomycin sputum in preservative, type …………… Kanamycin INH Rifampicin Pyrazinamide Ofloxacin µg/ml result follow-up at …. months after treatment Requested tests: microscopy (type _______ ) other specify):__________________ culture Person requesting examination: Name:_________________________ * Information that can be disclosed optionally Date: _____/______/20_____ ID = identification number or code DST (first / second line) Position:________________ Signature:________________ 37 Storage of strains • As part of good laboratory practice, cultures should be stored in appropriate conditions: – to preserve viability; – for safety reasons. • Viability will decline over time if bacteria are stored at room temperature or at 4 ºC. (Check national policy on strain storage.) 38 Storage of strains • Short-term storage: – 4 ºC (1 year solid) – 20 ºC (2 weeks) – liquid cultures – no more than 1 month. Long-term storage of patient cultures: – –20 ºC. Long-term storage of reference cultures: – –20 ºC. 39 Storage of strains • • Liquid media Skim milk 40 True and false exercise 1. DST is considered to be a procedure that risks generating aerosols. 2. Misidentification of a strain can lead to clinically irrelevant DST results. 3. Modified proportion method on LJ is currently considered as the reference method for DST of first-line drugs 4. Results should be reported only if quality assurance criteria are satisfied. 41 Module review: take-home messages The proportion method is valid for susceptibility testing of M. tuberculosis complex with anti-TB drugs. The proportion method is considered to be a reference standard, against which other routine methods should be assessed. The proportion method determines the percentage of growth of a defined inoculum on a drug-free control medium vs. growth on culture media containing the critical concentration of an anti-TB drug. Slants must be read after 4 weeks of incubation for a provisional result and after 6 weeks of incubation for the definitive interpretation of results. The critical concentration to define a resistant strain is 1% of the inoculum. Test with invalid growth control should be repeated. 42 Self-assessment • Explain the differences between direct and indirect DST methods. • List the possible errors in performing the proportion method. • List the consequences of a false resistance. • List the consequences of a false sensitivity. 43